MRNA Is Promising A Breakthrough In Fighting Cancer
When it comes to cancer, there's innovation both on the diagnostics and the treatment front thanks to messenger RNA, or mRNA, a genetic material we all got acquainted with during the COVID-19 era as i
BenzingaApr 29 10:02 ET
Mainz Biomed Reports Topline Results From Pooled Study Evaluating Novel MRNA Biomarkers And Proprietary AI Algorithm For Integration Into Pivotal FDA PMA Clinical Trial For Next Generation Colorectal Cancer Diagnostic
Groundbreaking topline results demonstrated sensitivity for colorectal cancer of 92% with specificity of 90% and best-in-class sensitivity for advanced adenoma of 82%690 subjects analyzed including pr
BenzingaApr 25 09:30 ET
Mainz Biomed Secures New Funding Agreement
TipRanksApr 19 07:29 ET
Express News | Cantor Fitzgerald Reiterates Neutral on Mainz Biomed
Moomoo 24/7Apr 12 09:58 ET
Analysts' Top Healthcare Picks: Mainz Biomed B.V. (MYNZ), Century Therapeutics (IPSC)
TipRanksApr 12 06:20 ET
Express News | Mainz Biomed NV : H.c. Wainwright Cuts Target Price to $2 From $3
Moomoo 24/7Apr 12 06:08 ET
Mainz Biomed 2023 Rev $895,500 >MYNZ
Mainz Biomed 2023 Rev $895,500 >MYNZ
Dow JonesApr 9 08:03 ET
Press Release: Mainz Biomed Reports Full Year 2023 Financial Results
Mainz Biomed Reports Full Year 2023 Financial Results ColoAlert(R) Revenue Increased 69% Year Over Year; Net Loss in Line with Previous Year; Cash Balance at Year End of $7.1 Million BERKELEY, Calif
Dow JonesApr 9 08:01 ET
Pharma's Post-Pandemic Story To Unlock A Cancer-Free Era
Pfizer (NYSE:PFE) and Moderna (NASDAQ:MRNA) did not only earn billions of dollars from their COVID-19 leading products but also rose to fame for saving the world from an unforeseen pandemic. But, in a
BenzingaApr 2 10:17 ET
Mainz Biomed Organizes HALLO DOC! Event to Highlight Innovations in Colorectal Cancer Treatment
Stockhouse Mar 19 08:01 ET
Mainz Biomed: Webinar on Early Detection of Colorectal Cancer - Exploring New Laboratory Diagnostic Options
BERKELEY, Calif. and MAINZ, Germany, March 18, 2024 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) ("Mainz Biomed" or the "Company"), a leader in molecular genetics diagnostic solutions for early cancer detection,
GlobeNewswireMar 18 08:01 ET
Mainz Biomed Presents ColoAlert at UDH Congress 2024: Leading the Way in Evidence-Based Cancer Screening Innovations
BERKELEY, Calif. and MAINZ, Germany, March 12, 2024 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) ("Mainz Biomed" or the "Company"), a leader in molecular genetics diagnostic solutions for early cancer detection,
GlobeNewswireMar 12 08:01 ET
Mainz Biomed Is Maintained at Buy by HC Wainwright & Co.
Mainz Biomed Is Maintained at Buy by HC Wainwright & Co.
Dow JonesMar 6 12:13 ET
HC Wainwright & Co. Maintains Buy on Mainz Biomed, Lowers Price Target to $3
HC Wainwright & Co. analyst Yi Chen maintains Mainz Biomed (NASDAQ:MYNZ) with a Buy and lowers the price target from $5 to $3.
BenzingaMar 6 12:03 ET
Mainz Biomed Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 03/06/2024 215.79% HC Wainwright & Co. $5 → $3 Maintains Buy 11/21/2023 — Cantor Fitzgerald Downgrades Ov
BenzingaMar 6 12:01 ET
Analysts Are Bullish on Top Healthcare Stocks: Iterum Therapeutics (ITRM), Mainz Biomed B.V. (MYNZ)
TipRanksMar 6 11:30 ET
Mainz Biomed Partners With Trusted Health Advisors to Support U.S. Go-To-Market Strategy for Next Generation Early Colorectal Cancer Diagnostic
Dr. Jay Wohlgemuth, former Chief Medical & Scientific Officer of Quest Diagnostics and Dr. Ray Tabibiazar, a seasoned industry executive, to lead collaborationMainz Biomed's Pivotal FDA PMA clinical trial
GlobeNewswireMar 5 08:01 ET
Gynecology Plays A Pivotal Role In Colorectal and Endometrial Cancer Screening
When it comes to cancer, one cannot overestimate the importance of early detection. Especially when it comes to colorectal and endometrial cancer that even big pharma companies don't have a good track
BenzingaFeb 28 10:54 ET
Mainz Biomed to Showcase at the Gynecology Conference in Stuttgart, Germany, Strengthening Connections Within the Medical Community
BERKELEY, Calif. and MAINZ, Germany, Feb. 27, 2024 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) ("Mainz Biomed" or the "Company"), a leader in molecular genetics diagnostic solutions for early cancer detection,
GlobeNewswireFeb 27 08:01 ET
Outdoing Cancer Requires Pharma To Go Beyond Merely Revolutionizing Existing Treatment
Pfizer Inc (NYSE:PFE) is among the many pharmaceutical companies that turned to oncology in response to sinking demand for its COVID-19 products and near patent expiration dates for its several top-se
BenzingaFeb 22 12:21 ET
No Data
No Data